Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionSmith, Moore & Co.
Latest Disclosed Ownership1,870 shares
Latest Disclosed Value $ 285,703
Smith, Moore & Co. reports 5.98% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 5, 2026 - Smith, Moore & Co. filed a 13F-HR form disclosing ownership of 1,870 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $285,642 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 1,989 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -5.98% during the quarter. The current value of the position is $268,644 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 1,870 -119 -5.98 286 4.01 0.0208
2026-01-23 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 1,989 0 0.00 274 7.45 0.0207
2025-11-12 2025-09-30 13F NOVARTIS PONSORED ADR 66987V109 1,989 34 1.74 255 8.05 0.0195
2025-08-13 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 1,955 8 0.41 237 8.76 0.0199
2025-05-15 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,947 -277 -12.46 217 0.46 0.0201
2025-02-13 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,224 277 14.23 216 -3.14 0.0198
2024-11-12 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 1,947 0 0.00 224 7.73 0.0214
2024-08-14 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 1,947 1,947 207 0.0214
2019-08-15 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -2,103 -100.00 0 -100.00
2019-05-07 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,103 -897 -29.90 202 -21.40 0.0481
2019-02-15 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,000 -185 -5.81 257 -6.20 0.0698
2018-11-15 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,185 100 3.24 274 17.60 0.0625
2018-08-14 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,085 4 0.13 233 -6.43 0.0585
2018-05-14 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,081 0 0.00 249 -3.86 0.0667
2018-02-09 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,081 -50 -1.60 259 -3.72 0.0698
2017-11-02 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,131 228 7.85 269 11.16 0.0765
2017-08-11 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,903 53 1.86 242 14.15 0.0811
2017-05-08 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,850 0 0.00 212 1.92 0.0761
2017-02-02 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,850 250 9.62 208 1.46 0.0793
2016-11-14 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,600 2,600 205 0.0824
2016-05-12 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -2,450 -100.00 0 -100.00
2016-02-12 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,450 0 0.00 211 -6.22 0.1049
2015-10-14 2015-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 2,450 100 4.26 225 -2.60 0.1248
2015-10-13 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,350 231
2015-07-31 2015-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,350 0 0.00 231 -0.43 0.1174
2015-05-08 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,350 0 0.00 232 6.42 0.1225
2015-02-10 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,350 100 4.44 218 2.83 0.1162
2014-11-07 2014-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,250 0 0.00 212 3.92 0.1182
2014-07-24 2014-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,250 2,250 204 0.1237
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.